Ibrutinib and Rituxan for Chronic GVHD
Clinical trial NCT04235036 · TERMINATED
Trial details
- NCT number
- NCT04235036
- Sponsor
- Northside Hospital, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-16
- Primary completion
- 2022-12-23
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.